Somatic gene therapy for dyslipidemias
- 1 September 1999
- journal article
- review article
- Published by Elsevier in Journal of Laboratory and Clinical Medicine
- Vol. 134 (3) , 194-214
- https://doi.org/10.1016/s0022-2143(99)90199-3
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Premature Atherosclerosis in Patients with Familial Chylomicronemia Caused by Mutations in the Lipoprotein Lipase GeneNew England Journal of Medicine, 1996
- Range of serum cholesterol values in the population developing coronary artery diseaseThe American Journal of Cardiology, 1995
- Expression of Human α1-Antitrypsin in Mouse After in Vivo Gene Transfer to Hepatocytes by Small LiposomesBiochemical and Biophysical Research Communications, 1994
- Prolonged Transgene Expression in Cotton Rat Lung with Recombinant Adenoviruses Defective in E2aHuman Gene Therapy, 1994
- Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosisNature Genetics, 1994
- Kinetic evidence for phosphatidylethanolamine and triacylglycerol as preferential substrates for hepatic lipase in HDL subfractions: Modulation by changes in the particle surface, or in the lipid coreBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1990
- Ten-Year Mortality from Cardiovascular Disease in Relation to Cholesterol Level among Men with and without Preexisting Cardiovascular DiseaseNew England Journal of Medicine, 1990
- cDNA sequence of human apolipoprotein(a) is homologous to plasminogenNature, 1987
- Mouse preheparin plasma contains high levels of hepatic lipase with low affinity for heparinBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1986
- The human LDL receptor: A cysteine-rich protein with multiple Alu sequences in its mRNACell, 1984